» Articles » PMID: 36698620

Examining the Diagnosis and Treatment Experiences of People Living With Autoimmune Gastritis and Pernicious Anemia

Overview
Journal J Patient Exp
Specialty Health Services
Date 2023 Jan 26
PMID 36698620
Authors
Affiliations
Soon will be listed here.
Abstract

There is limited research evaluating the diagnosis and treatment of patients with autoimmune gastritis (AIG) and pernicious anemia (PA). We used a 2-phase data collection process to examine the literature and individual patient accounts. Phase one comprised a systematically conducted literature review focusing on diagnosis and treatment, relationships with healthcare practitioners and health-related quality of life (HRQOL). Phase two involved analysis of individual accounts via posts in online patient forums. We identified 6 main themes: the diagnosis journey, seeking treatment, patient-provider relationships, HRQOL, patient disempowerment, and the "expert patient." Our findings confirm significant knowledge gaps concerning AIG/PA across the healthcare community. These have a cascading effect starting with delays in diagnosis and poor treatment protocols and often lead to complete withdrawal from care seeking. The establishment of standard consensus guidelines and improved clinical awareness should be urgently addressed. Interventions that better help patients understand their illness are also needed to improve psychological health. Without these changes disengagement from health systems, and poor health outcomes, will continue for this population group.

Citing Articles

Vitamin B.

Wolffenbuttel B, Owen P, Ward M, Green R BMJ. 2023; 383:e071725.

PMID: 37984968 PMC: 10658777. DOI: 10.1136/bmj-2022-071725.


Homocysteine-a retrospective and prospective appraisal.

McCaddon A, Miller J Front Nutr. 2023; 10:1179807.

PMID: 37384104 PMC: 10294675. DOI: 10.3389/fnut.2023.1179807.

References
1.
Miceli E, Vanoli A, Lenti M, Klersy C, Di Stefano M, Luinetti O . Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience. Aliment Pharmacol Ther. 2019; 50(11-12):1172-1180. DOI: 10.1111/apt.15540. View

2.
Zhang Y, Weck M, Schottker B, Rothenbacher D, Brenner H . Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013; 22(5):821-6. DOI: 10.1158/1055-9965.EPI-12-1343. View

3.
Afsar I, Sener A, Kaya S . Prevalence of high-level positivity of anti-parietal cell antibodies in Turkish population. Scand J Gastroenterol. 2015; 50(10):1304-5. DOI: 10.3109/00365521.2015.1031169. View

4.
Hooper M, Hudson P, Porter F, McCaddon A . Patient journeys: diagnosis and treatment of pernicious anaemia. Br J Nurs. 2014; 23(7):376-81. DOI: 10.12968/bjon.2014.23.7.376. View

5.
Green R . Vitamin B deficiency from the perspective of a practicing hematologist. Blood. 2017; 129(19):2603-2611. DOI: 10.1182/blood-2016-10-569186. View